FDA Grants Fenwal New 510(k) Clearance

LAKE ZURICH, Ill., Aug. 12 /PRNewswire/ — Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal a new 510(k) clearance for its Amicus® blood cell separator. The new clearance involves the use of the Amicus® separator with InterSol® platelet …